Syndax Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SNDX and other ETFs, options, and stocks.

About SNDX

Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaged in the development of cancer therapies. Its product candidates include SNDX-5613 and SNDX-6352. 

CEO
Michael A. Metzger
CEOMichael A. Metzger
Employees
184
Employees184
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
2005
Founded2005
Employees
184
Employees184

SNDX Key Statistics

Market cap
1.43B
Market cap1.43B
Price-Earnings ratio
-4.62
Price-Earnings ratio-4.62
Dividend yield
Dividend yield
Average volume
2.42M
Average volume2.42M
High today
$17.87
High today$17.87
Low today
$16.61
Low today$16.61
Open price
$16.72
Open price$16.72
Volume
2.19M
Volume2.19M
52 Week high
$25.34
52 Week high$25.34
52 Week low
$14.50
52 Week low$14.50

Analyst ratings

93%

of 15 ratings
Buy
93.3%
Hold
6.7%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.